Actinium Pharmaceuticals Inc (NYSE American:ATNM)

0.6299
Delayed Data
As of Jun 22
 -0.0421 / -6.26%
Today’s Change
0.33
Today|||52-Week Range
1.33
-5.08%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close0.67
Today’s open0.69
Day’s range0.63 - 0.71
Volume1,911,130
Average volume (3 months)1,199,957
Market cap$41.7M
Data as of 8:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+20.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.33+19.19%
GNMXAevi Genomic Medicin...+0.06+5.26%
JNPJuniper Pharmaceutic...+0.20+2.25%
SNSSSunesis Pharmaceutic...-0.02-0.93%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateJuly 30, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$26.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Sandesh Seth
Principal Financial &
Accounting Officer
Steve Oloughlin
Corporate headquarters
New York, New York

Forecasts